Real-time enrollment status for this castrate resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT05488548 |
| Recruiting Status | Recruiting |
| Condition | Castrate Resistant Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Epigenetix, Inc. |
| Last Updated on CT.gov | January 14, 2025 (Jan 14, 2025) |
As of July 13, 2026: Clinical trial NCT05488548 is currently recruiting participants. This clinical trial study for castrate resistant prostate cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Epigenetix, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05488548 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05488548 was last updated Jan 14, 2025 (January 14, 2025). HelloStudys verifies this status automatically.